Disease | intestinal disease |
Comorbidity | C0007113|rectal carcinoma |
Sentences | 2 |
PubMedID- 20128025 | Aim: to assess patients' understanding for the reasons for taking 5-aminosalicylic acid or ursodeoxycholic acid as chemoprophylaxis against colorectal carcinoma associated with inflammatory bowel disease (ibd). |
PubMedID- 21689324 | Aim: the study assessed the clinicopathological features and survival rates of inflammatory bowel disease (ibd) patients with colorectal carcinoma (crc), which accounts for approximately 15% of all ibd associated death. |
Page: 1